Skip to content

Insights

Pharma supply chain insights.

Showing news. Posts 1 to 7 of 7.

News

A Controlant Saga device standing on a white surface, its screen reading 20.5 °C
News

SpotSee and Controlant announce strategic collaboration to expand shipment visibility and last-mile proof for life sciences

SpotSee and Controlant today announced a strategic collaboration designed to help life sciences organizations expand shipment visibility, strengthen proof of condition and scale monitoring programs more efficiently across temperature-sensitive supply chains.

Read
Abstract network of pale blue nodes and connecting lines on a dark field
News

Results of Controlant’s Annual General Meeting: 5 May 2025

Controlant reports 2024 results, announces new board members and roadmap toward profitability in 2025, Kópavogur, Iceland, 5 May 2025, Controlant hf., a global leader in real-time supply chain visibility solutions for the pharmaceutical industry, held its Annual General Meeting (AGM) today. All proposals of the Board of Directors to the meeting were approved. The Company’s financial results for 2024 and outlook for 2025 were presented and two new board members were elected.

Read
CDP discloser badge
News

Controlant raises its CDP rating with progress on climate issues

Controlant’s coordinated action on climate issues has been awarded a B rating by the Climate Disclosure Project (CDP). The rating marks an improvement from last year’s B- rating and highlights the company’s steadfast progress toward a low-carbon economy.

Read
Controlant executive leadership, co-CEOs Gisli Herjolfsson Trausti Thormundsson
News

Controlant strengthens executive leadership and simplifies operating model to drive growth

Following the successful closing of a $35 million funding round, Controlant today announced changes to its executive leadership as well as a simplification of the operating model to improve execution power and reduce costs.

Read
A researcher in a mask and lab coat working with sample trays at a microscope
Press release

Controlant closes a $35 million funding round to advance market expansion and strategic product development

Controlant announces that it has successfully completed a $35 million financing round to seize opportunities in the ongoing digital transformation of pharma supply chains. The funding consists of $25 million in equity raised by new investors and current shareholders as well as a $10 million debt facility.

Read
A Controlant Saga device standing on a white surface, its screen reading 20.5 °C
Press release

Controlant and SmartCAE to transform lane risk assessment and thermal packing selection in pharma

Controlant, a global leader in real-time supply chain monitoring, and SmartCAE, a pioneer in cold chain simulation, have announced a new partnership. The collaboration aims to transform thermal packaging solutions for the pharmaceutical industry and logistics service providers by combining Controlant’s expertise in pharma supply chains with SmartCAE’s powerful engine for thermal packaging simulation and lane risk assessment, to improve safety, efficiency, and sustainability.

Read
Front view of a Controlant Saga device screen showing a shipment in progress at 23.5 °C
News

Controlant and FDK announce strategic partnership

Controlant, a global leader in pharma supply chain monitoring and automation, is proud to announce a strategic partnership with FDK Corporation (a subsidiary of Fujitsu), renowned for its expertise in battery technology. This collaboration will see Controlant leveraging FDK’s cutting-edge Nickel Metal Hydride (NiMH) batteries in its solutions, strengthening its commitment to reliability, sustainability, and performance.

Read

See the platform working on shipments like yours

Tell us what you ship and where, and we'll show you the platform on routes and products like yours.